Physician profile
Thomas Lee Hoffman
NPI 1386624062
$4,154.71
in general payments reported to CMS, 2019-2025
18 companies · $189 in 2025
The $189 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $728 · 2020: $495 · 2021: $861 · 2022: $518 · 2023: $898 · 2024: $466 · 2025: $189.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $897 · Travel and Lodging: $655.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $897.44 |
| Travel and Lodging | $655.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $1,089.53 | 2021-2025 | |
| Smith+Nephew, INC. | $946.05 | 2019-2025 | Grafix Pl, Renasys Go V2 Home, Renasys Touch |
| Organogenesis INC. | $525.76 | 2019-2025 | Puraply, Affinity, Apligraf |
| Tactile Systems Technology INC | $263.00 | 2019-2024 | Flexitouch Plus, Entre Plus |
| Misonix INC | $256.17 | 2019-2021 | |
| Abbvie INC. | $162.95 | 2021-2025 | |
| Trice Medical, INC. | $158.54 | 2022 | |
| Paratek Pharmaceuticals, INC. | $136.29 | 2019-2025 | Nuzyra |
| Allergan, INC. | $107.81 | 2019-2020 | |
| Urgo Medical North America, LLC | $104.63 | 2023-2024 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap, Urgoclean Ag |
| Osiris Therapeutics INC. | $83.47 | 2019 | |
| Amgen INC. | $72.85 | 2024 | Krystexxa |
| Celularity INC. | $54.00 | 2019 | |
| Reddress USA, INC. | $50.24 | 2022 | |
| Molnlycke Health Care US, LLC | $48.74 | 2023-2024 | Mepilex Border Sacrum, Mextra Superabsorbant, Mepilex Border Flex |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $42.16 | 2019 | |
| Bioventus LLC | $28.76 | 2022 | |
| Abbott Laboratories | $23.76 | 2023 | Proclaim |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Hoffman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.